D Keith Grossman
CIK 1218702 · Executive Chairman · last filed 2026-10-13
D Keith Grossman is an Executive Chairman who has filed 117 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for MMEDV, was dated Oct 13, 2026. Across all open-market trades the lifetime net is −$10.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $32.2M across reported positions. 8 SEC filings were submitted jointly with Zeltiq Aesthetics Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ISRG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN JOSE, CA 95134
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MMEDV | Director | 25,684 | — | — | $0 | 1 | 2026-10-13 |
| OM | Director | 37,430 | $4.08 | $152.7K | -$1.10M | 19 | 2026-06-05 |
| MMED | Director | 13,889 | $18.66 | $259.2K | $0 | 1 | 2026-03-11 |
| NEVRO CORP (NVRO) Delisted | Director | 0 | $5.84 | $0 | $939.0K | 43 | 2025-04-03 |
| ViewRay, Inc. (VRAY) Delisted | Director | 100,855 | $0.03 | $2.5K | $0 | 6 | 2021-01-05 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 0 | — | — | $0 | 6 | 2017-04-28 |
| THOR | President & Chief Exec Officer | 602,050 | $25.39 | $15.29M | -$2.32M | 20 | 2015-10-08 |
| CONCEPTUS INC (CPTS) Delisted | President & CEO | 204,882 | — | — | $0 | 3 | 2013-02-11 |
| ISRG | Director | 36,450 | $451.63 | $16.46M | -$8.12M | 13 | 2010-04-23 |
| KYPHON INC (KYPH) Delisted | Director | 64 | — | — | $0 | 2 | 2007-05-09 |
Recent Filings
117 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-13 | MMEDV | Grant (A) | +11,795 | $0 | EDGAR |
| 2026-06-05 | OM | Grant (A) | +10,667 | $0 | EDGAR |
| 2026-03-11 | MMED | Grant (A) | +13,889 | $0 | EDGAR |
| 2025-06-04 | OM | Grant (A) | +8,983 | $0 | EDGAR |
| 2025-04-03 | NEVRO CORP (NVRO) Delisted | Disp (D) | −228,552 | $0 | EDGAR |
| 2025-03-11 | OM | Mixed | +187,500 | $0 | EDGAR |
| 2025-03-11 | NEVRO CORP (NVRO) Delisted | Tax (F) | −1,641 | -$9.5K | EDGAR |
| 2025-03-04 | NEVRO CORP (NVRO) Delisted | Mixed | +2,662 | -$11.9K | EDGAR |
| 2024-12-04 | NEVRO CORP (NVRO) Delisted | Tax (F) | −928 | -$4.0K | EDGAR |
| 2024-09-05 | NEVRO CORP (NVRO) Delisted | Tax (F) | −1,020 | -$5.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.